Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Pharmacogenetics and Genomics|February 24, 2006
Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenzJue Wang, Anders Sönnerborg, Anders Rane, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 12, 2013
Atorvastatin treatment induces uptake and efflux transporters in human liverLinda Björkhem-Bergman, Helena Bergström, Maria Johansson, et al.
Biochimie|August 22, 2012
DNA methylation dynamics in the hepatic CYP3A4 gene promoterMarina Kacevska, Maxim Ivanov, Annika Wyss, et al.
Biochemical and Biophysical Research Communications|November 19, 2002
Linkage between the CYP2C8 and CYP2C9 genetic polymorphismsUmit Yasar, Stefan Lundgren, Erik Eliasson, et al.
Pharmacogenetics|June 4, 2002
5alpha-reductase 2 polymorphisms as risk factors in prostate cancerTorbjörn Söderström, Mia Wadelius, Swen-Olov Andersson, et al.
Pharmacogenetics|December 3, 2003
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarctionUmit Yasar, Anna M Bennet, Erik Eliasson, et al.
Pharmacogenetics and Genomics|May 23, 2008
Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymesJenny Jakobsson Schulze, Mattias Lorentzon, Claes Ohlsson, et al.
Biological & Pharmaceutical Bulletin|December 4, 2015
Effects of Angiotensin II Receptor Blockers on Metabolism of Arachidonic Acid via CYP2C8Asuna Senda, Yuji Mukai, Takaki Toda, et al.
Frontiers in Endocrinology|May 31, 2013
Non-steroidal anti-inflammatory drugs do not influence the urinary testosterone/epitestosterone glucuronide ratioJonas Lundmark, Nina Gårevik, John-Olof Thörngren, et al.
Pageof 12